Share it with your friends:
AstraZeneca, a world-renowned laboratory, would have admitted that its covid-19 vaccine can cause thrombosis.
Through legal documents, AstraZeneca has accepted that its vaccine could induce a rare side effect, British media reported.
This statement came in the context of a class action lawsuit that was initiated in the United Kingdom.
dozens of patients have alleged that the drug would cause serious injuries in a limited number of cases.
The pharmaceutical company’s Covid-19 vaccine was developed in collaboration with the University of Oxford.
In the known and reported cases, the patients presented side effects which led to the death and serious injuries to their bodies.
The lawsuit claims that the vaccine has caused a serious adverse reaction in some people, which “devastatingly affected several families.”
Vaccination was and continues to be a crucial tool in the fight against covid-19.
There are multiple manufacturers, including AstraZeneca, which distributed doses worldwide within the framework of the health emergency.
In the first moment The lab rejected the claims, but then, last February, he accepted, in a legal document he presented to the High Court that his formulation “may, in very rare cases, cause TTS.”
That is, it can cause thrombosis syndrome with thrombocytopenia, which causes people to have blood clots and a low blood platelet count.
The High Court of the United Kingdom has so far received 51 cases from people who claim to have suffered from these conditions or their relatives.
AstraZeneca dismissed a patient’s case
The local newspaper The Telegraph points out that the first case reported to the judiciary from the United Kingdom was Jamie Scott.
The patient suffered an irreversible brain injury following the formation of a blood clot and a brain hemorrhage.
His relatives allege that the effects began after he was vaccinated in April 2021 with the AstraZeneca biological.
The company dismissed the argument in a letter sent to Scott’s lawyers in May last year.
The World Health Organization (WHO) In 2022, it released the notes of the Global Advisory Committee on Vaccine Safety related to the side effects of the AstraZeneca drug.
The document warned of a “very rare new type of adverse event, known as thrombosis syndrome with thrombocytopenia, after administration of this vaccine.
This syndrome involves rare and serious blood coagulation disorders associated with low platelet counts.